AVTX
Price
$14.00
Change
+$0.60 (+4.48%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
176.24M
BLTE
Price
$78.50
Change
+$2.90 (+3.84%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
2.48B
43 days until earnings call
Interact to see
Advertisement

AVTX vs BLTE

Header iconAVTX vs BLTE Comparison
Open Charts AVTX vs BLTEBanner chart's image
Avalo Therapeutics
Price$14.00
Change+$0.60 (+4.48%)
Volume$1.39K
Capitalization176.24M
Belite Bio
Price$78.50
Change+$2.90 (+3.84%)
Volume$674
Capitalization2.48B
AVTX vs BLTE Comparison Chart in %
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. BLTE commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Buy and BLTE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (AVTX: $13.40 vs. BLTE: $75.60)
Brand notoriety: AVTX and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 86% vs. BLTE: 140%
Market capitalization -- AVTX: $176.24M vs. BLTE: $2.48B
AVTX [@Biotechnology] is valued at $176.24M. BLTE’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while BLTE’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 4 bearish.
  • BLTE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than AVTX.

Price Growth

AVTX (@Biotechnology) experienced а +24.07% price change this week, while BLTE (@Biotechnology) price change was +8.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +14.86%, and the average quarterly price growth was +84.67%.

Reported Earning Dates

BLTE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($2.48B) has a higher market cap than AVTX($176M). AVTX YTD gains are higher at: 80.350 vs. BLTE (19.810). BLTE has higher annual earnings (EBITDA): -50.43M vs. AVTX (-59.78M). AVTX has higher revenues than BLTE: AVTX (441K) vs BLTE (0).
AVTXBLTEAVTX / BLTE
Capitalization176M2.48B7%
EBITDA-59.78M-50.43M119%
Gain YTD80.35019.810406%
P/E Ratio1.99N/A-
Revenue441K0-
Total Cash113MN/A-
Total Debt679KN/A-
FUNDAMENTALS RATINGS
AVTX: Fundamental Ratings
AVTX
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTXBLTE
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 5 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 13 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GERUX11.210.05
+0.45%
Goldman Sachs Em Mkts Eq Insghts R6
JERAX12.210.05
+0.41%
Janus Henderson Global Real Estate A
STMOX35.120.09
+0.26%
Sterling Capital Real Estate C
TIBOX32.280.07
+0.22%
Thornburg Investment Income Builder R6
AVUNX20.970.02
+0.10%
Avantis® U.S. Equity G

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+3.08%
FGEN - AVTX
57%
Loosely correlated
-1.68%
MEOBF - AVTX
46%
Loosely correlated
+9.37%
MRSN - AVTX
37%
Loosely correlated
+3.50%
PGEN - AVTX
34%
Loosely correlated
-2.40%
BDRX - AVTX
32%
Poorly correlated
+0.45%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+2.08%
RAIN - BLTE
48%
Loosely correlated
-3.98%
ACOG - BLTE
24%
Poorly correlated
+0.54%
AVTX - BLTE
23%
Poorly correlated
+3.08%
APLS - BLTE
22%
Poorly correlated
+2.99%
ALEC - BLTE
22%
Poorly correlated
+5.06%
More